O'Shaughnessy Asset Management, LLC Myriad Genetics Inc Transaction History

O'Shaughnessy Asset Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$27.23 - $45.56 $87,571 - $146,520	-3,216 Closed	0 $0
Q3 2018 Nov 06, 2018	SELL	$37.57 - $50.34 $1,991 - $2,668	-53 Reduced 1.62%	3,216 $147,000
Q2 2018 Aug 10, 2018	SELL	$27.75 - $40.17 $42,374 - $61,339	-1,527 Reduced 31.84%	3,269 $121,000
Q1 2018 May 08, 2018	SELL	$28.83 - $41.01 $35,201 - $50,073	-1,221 Reduced 20.29%	4,796 $142,000
Q4 2017 Feb 13, 2018	BUY	$28.45 - $37.14 $88,451 - $115,468	3,109 Added 106.91%	6,017 $207,000
Q3 2017 Nov 13, 2017	SELL	$24.01 - $36.2 $41,297 - $62,264	-1,720 Reduced 37.17%	2,908 $105,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,628	4,628 $120,000

238

92.7M

117K

113K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.77B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.